Domenic J. Ferrante, Director at Finch Therapeutics Group, Inc. (FNCH), bought 193,319 shares at $17.00 ($1.7M) on 2021-03-23, disclosed to the SEC on 2021-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 90,378 | $0 | 0.0% |
| 2 | $17.00 | 102,941 | $1.7M | 100.0% |
| Total | $9.05 avg | 193,319 | $1.7M | 100% |
| Filing → |
| DPZ | SELL | 2010-10-25 | $4.0M | — | Filing → |
| DPZ | SELL | 2010-03-22 | $3.0M | — | Filing → |
| TARG | BUY | 2007-11-02 | $5.8M | — | Filing → |